Stockscreener 앱 받기
63.65
0.47%
-0.23
전일 마감가:
$63.88
열려 있는:
$64.42
하루 거래량:
703.36K
Relative Volume:
0.40
시가총액:
$31.02B
수익:
$10.40B
순이익/손실:
$980.00M
주가수익비율:
32.23
EPS:
1.9749
순현금흐름:
$1.61B
1주 성능:
-14.19%
1개월 성능:
-17.76%
6개월 성능:
-14.05%
1년 성능:
-33.69%
1일 변동 폭
$63.54
$64.82
1주일 범위
$63.54
$74.82
52주 변동 폭
$63.54
$96.88
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
63.61 | 31.15B | 10.40B | 980.00M | 1.61B | 1.9749 |
ISRG
Intuitive Surgical Inc
|
449.77 | 160.61B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
150.12 | 43.60B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
40.08 | 35.40B | 29.14B | 1.07B | 1.52B | 1.1995 |
RMD
Resmed Inc
|
204.69 | 30.01B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | 개시 | William Blair | Mkt Perform |
| 2026-01-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-12-11 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-08-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-05-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 재확인 | BTIG Research | Buy |
| 2025-03-28 | 재확인 | Needham | Buy |
| 2025-03-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-24 | 재확인 | Needham | Buy |
| 2025-01-10 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 재확인 | Needham | Buy |
| 2024-11-12 | 재확인 | Needham | Buy |
| 2024-10-10 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 개시 | Goldman | Buy |
| 2024-03-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 개시 | Bernstein | Outperform |
| 2023-12-18 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | 업그레이드 | Societe Generale | Sell → Hold |
| 2022-12-22 | 개시 | Mizuho | Buy |
| 2022-11-17 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2022-08-11 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-05-12 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-11 | 개시 | BofA Securities | Buy |
| 2022-01-18 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 개시 | Oppenheimer | Perform |
| 2021-07-14 | 개시 | Deutsche Bank | Buy |
| 2021-05-06 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-03-22 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-11-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-07-06 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-07-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-04-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Argus | Hold → Buy |
| 2020-03-24 | 업그레이드 | Societe Generale | Sell → Hold |
| 2020-03-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-26 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-01-08 | 개시 | Argus | Hold |
| 2019-10-29 | 개시 | Stephens | Equal-Weight |
| 2019-08-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-06-24 | 개시 | SVB Leerink | Mkt Perform |
| 2019-06-14 | 개시 | BTIG Research | Neutral |
| 2019-05-10 | 개시 | Robert W. Baird | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
모두보기
Alcon Inc 주식(ALC)의 최신 뉴스
Needham tracks April prescription trends for Alcon and Bausch + Lomb eye drugs - Investing.com Nigeria
Alcon Inc stock (CH0432492467): Eye care specialist eyes growth in contact lenses and surgery device - AD HOC NEWS
Bernstein Keeps Alcon at Outperform After Q1 Results; Estimates, Price Target Revised - marketscreener.com
ALC Maintains Overweight Rating -- Price Target Lowered to $86.0 - GuruFocus
ALC Maintains by Mizuho -- Price Target Lowered to $85.00 - GuruFocus
ALC Maintains Rating by Baird -- Price Target Lowered to $90 - GuruFocus
Here's why Alcon (ALC) is a strong value stock - MSN
Fewer cataract surgeries slow Alcon - WFMZ.com
A Quick Look at Today's Ratings for Alcon(ALC.US), With a Forecast Between $70.65 to $102.76 - Moomoo
Here's Why Alcon (ALC) is a Strong Value Stock - Yahoo Finance
Alcon forecasts 5%-7% sales growth and announces $1.5B share repurchase program amid reduced tariff assumption - MSN
Alcon Q1 2026 Sales Rise 10% as New Eye-Care Products Power Growth and $1.5 Billion Buyback - The Globe and Mail
Alcon: Results weren't bad; today's correction is a buying opportunity - marketscreener.com
BTIG lowers Alcon stock price target to $82 on lower valuation - Investing.com UK
Alcon declines 10% after Q1 revenue misses consensus - MSN
Alcon stock slides as Q1 sales miss expectations and reported profitability drops sharply - Quiver Quantitative
Alcon Kicks Off 2026 on Solid Results as New Innovations Pay Dividends - Morningstar
Alcon Q1 2026 Earnings Call Transcript - Benzinga
Alcon Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Swiss eye care firm Alcon’s quarterly revenue rises less than expected - WHTC
Alcon slides after revenue misses forecasts, operating profit falls sharply By Investing.com - Investing.com Canada
Alcon slides after revenue misses forecasts, operating profit falls sharply - Investing.com
Needham Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $100 - Moomoo
Alcon shares see BofA reiterate underperform on soft Q1 results By Investing.com - Investing.com India
Alcon shares see BofA reiterate underperform on soft Q1 results - Investing.com UK
Alcon Price Target Declines as AlphaValue/Baader Cuts Estimates on Rising Competition, Expenses - marketscreener.com
Earnings Preview: Alcon to Report Financial Results Pre-market on May 06 - Moomoo
Alcon Logs Lower Q1 Net Income; Net Sales, Other Revenue Rise - marketscreener.com
Alcon : Earnings Document (Q1 2026 Interim Financial Report) - marketscreener.com
Alcon Inc. (ALC) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (ALC) Alcon Posts Q1 Revenue $2.69B, vs. FactSet Est of $2.7B - marketscreener.com
Alcon Q1 Core Earnings, Revenue Rise; 2026 EPS Outlook Revised - marketscreener.com
Alcon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds - Business Wire
Alcon earnings on deck: Can new products drive double-digit growth? - Investing.com Canada
MSN Money - MSN
Alcon Inc. authorizes a Buyback Plan. - marketscreener.com
Earnings Snapshot: Alcon plans to offset FY ~$100M tariff impact, guides profit above consensus - MSN
Alcon Inc. (ALC) Stock Analysis: Unveiling a 27% Potential Upside Amidst Robust Revenue Growth - DirectorsTalk Interviews
ALC Stock Price, Quote & Chart | ALCON INC (NYSE:ALC) - ChartMill
Assessing Alcon (SWX:ALC) Valuation After Recent Share Price Weakness - Yahoo Finance
Alcon Board Change And Vision Research Progress Shape Investor Expectations - Yahoo Finance
US Startup PerZeption Inc. Announces Collaboration with Alcon Research - Yahoo Finance
Alcon Announces Results of 2026 Annual General Meeting - BioSpace
Alcon shareholders approve CHF 0.28 dividend, add Scott Herren - Stock Titan
BofA Securities Maintains Alcon(ALC.US) With Sell Rating, Cuts Target Price to $69.54 - Moomoo
How Alcon Inc. (ALC) Affects Rotational Strategy Timing - Stock Traders Daily
Alcon Stock Rises Following the FDA Approval of TRYPTYR - MSN
Is Alcon Inc (ALC) a Bargain After 3.4% Drop? GF Value Says Unde - GuruFocus
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
World Council of Optometry and Alcon Video Series Summarizes TFOS DEWS III - InvisionMag.com
Alcon Inc (ALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.06%
3.46%
자본화:
|
볼륨(24시간):